Showing results (291-300 of 325) with videos related to
Sort By:
Pageof 33
JAMA Surgery|May 9, 2014
Number of excised lymph nodes as a quality assurance measure for lymphadenectomy in melanomaCarlo Riccardo Rossi, Nicola Mozzillo, Andrea Maurichi, et al.Anticancer Research|December 7, 2016
Intraperitoneal Chemotherapy in Patients Pretreated for Ovarian Cancer Matched with Patients Treated with Parenteral ChemotherapyMaria Ornella Nicoletto, Alessandra Casarin, Alessandra Baldoni, et al.Frontiers in Endocrinology|November 1, 2021
Basal and Calcium-Stimulated Procalcitonin for the Diagnosis of Medullary Thyroid Cancers: Lights and ShadowsSimona Censi, Marta Di Stefano, Andrea Repaci, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 7, 2021
Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter studySylvie Bonvalot, Jay Wunder, Alessandro Gronchi, et al.Cancers|February 25, 2023
Management and Outcomes of Older Patients (Age ≥ 70 Years) with Advanced Soft Tissue Sarcoma and Role of Geriatric Assessment and Oncological Multidimensional Prognostic Index (Onco-MPI) in a Real-World SettingBenedetta Chiusole, Ilaria Tortorelli, Antonella Galiano, et al.Journal of Women'S Health (2002)|October 11, 2023
Sex Differences in Soft Tissue Sarcoma: Incidence, Clinicopathological Profile, Survival, and CostsAlessandra Buja, Massimo Rugge, Saveria Tropea, et al.Genetics|September 21, 2005
Post-transcriptional silencing and functional characterization of the Drosophila melanogaster homolog of human Surf1Mauro A Zordan, Paola Cisotto, Clara Benna, et al.The American Journal of Dermatopathology|April 15, 2026
Clinicopathologic Features and Treatment Outcomes of Squamoid Eccrine Ductal Carcinoma: A Comprehensive Retrospective SeriesFrancesco Fortarezza, Laura Gnesotto, Paolo Del Fiore, et al.Anticancer Research|October 15, 2010
Phase II study of neoadjuvant gemcitabine, pegylated liposomal doxorubicin, and docetaxel in locally advanced breast cancerGrazia Artioli, Artioli Grazia, Simone Mocellin, et al.Cancers|July 9, 2022
Direct Costs of Care for Adults with Soft Tissue Sarcomas: A Population-Based StudyMassimo Rugge, Alessandra Buja, Saveria Tropea, et al.Pageof 33